These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 19374297

  • 1. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R, Treeprasertsuk S, Phanthumchinda K.
    J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
    [Abstract] [Full Text] [Related]

  • 2. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF, Wang WX, Xue J, Zhao CB, You HZ, Lu JH, Gu Y.
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of therapeutic options used for myasthenia gravis.
    Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A.
    Ann Neurol; 2010 Dec; 68(6):797-805. PubMed ID: 21061395
    [Abstract] [Full Text] [Related]

  • 4. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T.
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [Abstract] [Full Text] [Related]

  • 5. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S, Myasthenia Gravis Clinical Study Group.
    Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
    [Abstract] [Full Text] [Related]

  • 6. Guillain-Barre syndrome: a clinical study in King Chulalongkorn Memorial Hospital.
    Areeyapinan P, Phanthumchinda K.
    J Med Assoc Thai; 2010 Oct; 93(10):1150-5. PubMed ID: 20973317
    [Abstract] [Full Text] [Related]

  • 7. Predictors of response to immunomodulation in patients with myasthenia gravis.
    Katzberg HD, Barnett C, Bril V.
    Muscle Nerve; 2012 May; 45(5):648-52. PubMed ID: 22499090
    [Abstract] [Full Text] [Related]

  • 8. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS, Goodman BP, Harper CM, Bosch PE, Hoffman-Snyder CR, Wellik KE, Wingerchuk DM, Demaerschalk BM.
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
    Lavrnić DB, Stojanović V, Marinković Z, Pavlović S, Vidaković A, Apostolski S.
    Srp Arh Celok Lek; 1995 May; 123(5-6):146-8. PubMed ID: 17974459
    [Abstract] [Full Text] [Related]

  • 10. Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis.
    Barnett C, Wilson G, Barth D, Katzberg HD, Bril V.
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):94-7. PubMed ID: 23154126
    [Abstract] [Full Text] [Related]

  • 11. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
    Liew WK, Powell CA, Sloan SR, Shamberger RC, Weldon CB, Darras BT, Kang PB.
    JAMA Neurol; 2014 May; 71(5):575-80. PubMed ID: 24590389
    [Abstract] [Full Text] [Related]

  • 12. Noninvasive ventilation in myasthenic crisis.
    Seneviratne J, Mandrekar J, Wijdicks EF, Rabinstein AA.
    Arch Neurol; 2008 Jan; 65(1):54-8. PubMed ID: 18195139
    [Abstract] [Full Text] [Related]

  • 13. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
    Gajdos P, Chevret S.
    Ann N Y Acad Sci; 2008 Jan; 1132():271-5. PubMed ID: 18096850
    [Abstract] [Full Text] [Related]

  • 14. Prethymectomy plasmapheresis in myasthenia gravis.
    Yeh JH, Chen WH, Huang KM, Chiu HC.
    J Clin Apher; 2005 Dec; 20(4):217-21. PubMed ID: 16035101
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P, Bril V.
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [Abstract] [Full Text] [Related]

  • 16. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L, Horváth R, Bárdosi Z, Szobor A.
    Acta Med Hung; 1994 Mar; 50(1-2):83-92. PubMed ID: 7638045
    [Abstract] [Full Text] [Related]

  • 17. [Association of plasmapheresis and high doses of intravenous immunoglobulins in the treatment of myasthenia gravis].
    Tatay J, Díez-Tejedor E, Frank A, Tejada J, Marrero C, Barreiro P.
    Rev Neurol; 1997 Sep; 25(145):1402-6. PubMed ID: 9377299
    [Abstract] [Full Text] [Related]

  • 18. Plasmapheresis before thymectomy in myasthenia gravis: routine versus selective protocols.
    El-Bawab H, Hajjar W, Rafay M, Bamousa A, Khalil A, Al-Kattan K.
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):392-7. PubMed ID: 19136275
    [Abstract] [Full Text] [Related]

  • 19. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
    Alipour-Faz A, Shojaei M, Peyvandi H, Ramzi D, Oroei M, Ghadiri F, Peyvandi M.
    Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
    [Abstract] [Full Text] [Related]

  • 20. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
    Zinman L, Bril V.
    Ann N Y Acad Sci; 2008 Mar; 1132():264-70. PubMed ID: 18567877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.